Blog
Game-changing Decision: New Genomic Techniques Approved!
π On 25.01.2024, AGRI and ENVI Committees agreed to relax rules for NGTs in plant breeding. π± NGT-1 plants exempt from labeling and safety assessment if equivalent to conventional breeds. π€ European Parliament and agriculture ministers to vote on modified proposal in February. βοΈ Environmental organizations disappointed with lack of political impact from anti-NGT campaigns.
Breakthrough Technology Solving Cell Therapy Bottleneck
𧬠The emergence of CRISPR-based gene editing has revolutionized cell therapy research. π¬ However, there is a significant bottleneck in the development and manufacturing of these therapies. βοΈ Critical to CRISPR-based gene editing is the effective delivery of editing components to target cells. π¬ Scaling the process for industrial manufacturing is a challenge, especially for therapies that require ex vivo editing of patient cells. β‘ Electroporation technology, specifically flow electroporation, offers a solution to this bottleneck. π Flow electroporation can transfect billions of cells at a time, providing scalability and process standardization. π This technology is already being used to enable CRISPR-based therapies and has played a critical role in the commercial approval of the first CRISPR-based cell therapy. 𧬠As companies and scientists develop more advanced cellular therapies, flow electroporation will continue to expand access to non-viral approaches. π While questions remain about the long-term safety and efficacy of genome editing therapies, CRISPR-related technologies offer new avenues for treating diseases.
Boosting Manufacturing Efficiency: AI’s Role in Cutting Costs and Enhancing Therapies
π§ͺ AI accelerates commercialization strategies by cutting costs and improving processes in advanced therapy manufacturing. π¬ 5 of batches fail, impacting health and revenues. π§ AI is crucial for complex therapies. π° Manufacturers need to optimize processes and reduce costs. π AI enables learning transfer and supports decision-making. π Industry 4.0 will use machine learning for real-time predictions and support.
Breaking: Evotec Reports Ex-CEO’s Suspicious Share Trading
ποΈ Insider trading involving the former CEO of Evotec was immediately reported by the company. βοΈππΌ
Breakthrough Treatment Prevents Blindness – BlueRock Leads the Way!
πΌ Biotechnology company BlueRock aims to prevent blindness by commercializing a groundbreaking ocular disease treatment. ππ
Boosting Machine Learning in Biotech with Prediction Stability
π Researchers have developed an approach to improve machine learning in biological sequence design. π₯ By considering prediction stability, the selection pool of antibodies can be expanded. π‘ This method allows machine learning algorithms to identify diverse sequences unrelated to training data. βοΈ The approach balances safety and success by finding a middle ground between prediction accuracy and uncertainty. π§ͺ Scientists validated this approach by designing antibodies against galectin-3 and successfully expressing a desired sequence. π¬ The researchers used their own multi-objective optimization software, but any off-the-shelf optimizer can be used. π This approach can be particularly useful in situations with limited data.
AstraZeneca Seeks UK Gov Aid to Boost Vaccine Production
π° AstraZeneca wants UK Gov aid to expand vaccine plant πΈ The pharmaceutical company seeks financial support to boost production capacity. π
Novartis Revolutionizes Cancer Therapy Production with Automation
π’ Novartis automates new radioligand therapy plant in Indianapolis! Increased supply and timely production for prostate cancer therapy. π¨βπ¬π€ππ
Revolutionary Tech Speeds Up Biotech Cell Line Development
π Abzena launches new tech to speed up cell line development in biotech industry. π HTSP allows rapid generation and evaluation of high-producing cell lines. πΌ Streamlining processes for biopharma companies. π©βπ¬π
Revolutionizing Bioprocessing with Machine Learning
π€ Machine learning (ML) reduces guesswork in bioprocessing by improving precision and minimizing errors. Factors like bio-kinetics, bioprocess responses, instrumentation, and environmental disturbances influence outcomes. ML can control bioreactors, identify errors in chromatography analysis, and selecting the right ML algorithm and model is crucial for real-time application. Combining ML-based tools with other analytical methods and correct data maximizes the benefits of ML in bioprocessing.
